Women with physical disabilities are often marginalized from mainstream healthcare services, and their reproductive health needs are not often met. The study aimed to explore the barriers faced by women with physical disabilities in reproductive health care utilization. This descriptive cross-sectional study was conducted between January to December 2021 among 83 conveniently selected women with physical disabilities of the reproductive age group (18-49 years). Data were obtained through face-to-face interviews from the participants using a pre-tested, semi-structured, interviewer-administered questionnaire. Among participants, the mean age was 29.3 years. All individuals reported that they experienced some sort of barrier to reproductive healthcare utilization. The Majority (50.6%) of the participants reported that disease was the cause of their disability. Traditional hurdles prevented 57% of participants from accessing reproductive healthcare, whereas 32.5% lacked familial support. Most (78.3%) of them said that accessing healthcare was expensive. More than half of the participants seeking reproductive healthcare found no wheelchair ramp or transfer aid. No service provider educated 69.9% of participants about reproductive healthcare services and rights. When asked about healthcare hurdles, individuals reported fear of poor care (75.9%), negative healthcare provider attitudes (68.7%), and communication issues with providers (67.5%). Some barriers to accessing reproductive health care services include high expenses, lack of family support, poor physical accessibility, lack of information, fear of poor care, negative attitudes of providers, and communication difficulties. Improving access to reproductive healthcare for women with physical disabilities requires addressing barriers and implementing necessary interventions.

Dengue (DENV), Chikungunya (CHIKV), and Zika (ZIKV) are emerging arboviral threats in Bangladesh, transmitted by Aedes mosquitoes thriving in urban Dhaka. Overlapping symptoms complicate diagnosis, and Bangladesh-specific data on arboviral antibody reactivity are limited. In four hospitals of Dhaka, we conducted a cross-sectional study on 438 febrile patients aged ≥10 years, collecting samples between September and December 2023 to describe arboviral antibody reactivity and their distribution across selected demographic and environmental characteristics. Rapid diagnostic tests (RDTs) for DENV and CHIKV were performed, followed by enzyme-linked immunosorbent assay (ELISA) on RDT-reactive samples. Participants had a mean age of 30 years (±13.5); two-thirds were male, and most lived in crowded, low-income households. RDTs indicated DENV/CHIKV antibody reactivity in 40% of participants; 170 samples underwent ELISA, suggesting DENV IgG reactivity in 33.5% and IgM reactivity in 15.5%. CHIKV IgG reactivity (0.7%) was low and ZIKV IgG was reactive in 21% of total samples, and IgM was reactive in one (0.2%); most ZIKV IgG-reactive samples also showed DENV IgG reactivity, suggesting cross-reactivity. DENV IgG and IgM reactivity were associated with lower education, while ZIKV IgM reactivity was associated with older age. Awareness of Aedes mosquitoes was low, and environmental risk factors were common. This study provides cross-sectional data on serological reactivity against DENV, CHIKV, and ZIKV among febrile patients attending four hospitals of Dhaka, without aiming to establish etiologic causes of illness. ZIKV IgG antibody reactivity requires confirmatory testing to distinguish true infections from other arboviral cross-reactivity. Strengthened community-based surveys, better public awareness, and sustained vector control are critical for reducing arboviral disease risks in urbanizing settings like Dhaka, Bangladesh.

Background: Vaccination has played a crucial role in mitigating the spread of COVID-19 and reducing its severe outcomes. While over 90% of Bangladesh’s population has received at least one COVID-19 vaccine dose, the comparative effectiveness of homologous versus heterologous booster strategies, along with the complex interplay of factors within the population, remains understudied. This study aimed to compare antibody responses between these booster approaches. Methods: This cross-sectional study enrolled 723 adults in urban Dhaka who had received COVID-19 booster doses within the last six months. Participants were grouped based on homologous or heterologous booster vaccination. Data were collected through structured household surveys, and 2 mL blood samples were collected for measuring antibody titers. Results: Heterologous booster recipients showed higher median antibody titers (8597.0 U/mL, IQR 5053.0–15,482.3) compared to homologous recipients (6958.0 U/mL, IQR 3974.0–12,728.5). In the adjusted analysis, the type of booster dose had no significant impact on antibody levels. However, the duration since the last booster dose was significantly associated with antibody levels, where each additional month since receiving the booster corresponded to approximately a 15–16% reduction in antibody levels (Adj. coeff: 0.85, 95% CI: 0.81, 0.88; p < 0.001). Participants over 40 years demonstrated higher antibody levels than younger individuals (Adj. coeff: 1.23, 95% CI: 1.07, 1.43; p = 0.005). Sex, BMI, and prior COVID-19 infection showed no significant associations with antibody levels after adjustment. Conclusion: The results underscore the complexity of immune responses across different demographic groups and suggest potential benefits of ongoing heterologous booster strategies in sustaining immunity.

Objective: This study aimed to explore the workplace safety experiences of health workers (doctors and nurses) at a tertiary hospital in Bangladesh. Materials and Methods: This was a descriptive cross-sectional study among conveniently selected 305 registered physicians and nurses working in the designated tertiary hospital. After obtaining the written informed consent, data was collected using face-to-face interviews with a pre-tested, semistructured, interviewer-administered questionnaire from December 2021 to January 2022. Frequency and proportion described the variables. Result: The mean age of the participants was 28.8 years. Female individuals constituted the majority, accounting for 69.2% of the total. Approximately 69.8% of individuals reported experiencing occupational health hazards. Psychological hazards were the most frequently reported (56.1%), followed by workplace-acquired health hazards (15.7%) and physical hazards (13.8%) among all participants. While 79.0% of the participants were aware of workplace health and safety, only 7.9% received safety training, and only 7.5% reported any occupational hazard to the hospital management. Conclusion: Healthcare personnel adjust to several professional hazards in a complicated series of events, as the study shows. The complexity of the healthcare environment poses considerable psychological and health hazards. Although there is good preparedness and procedure awareness, the analysis shows some crucial resources and training still need to be improved. Therefore, some strategic actions are needed to improve healthcare professionals’ safety and well-being in the modern healthcare environment through crucial resources and training.

Background/Aim: Patients with rifampicin resistant-tuberculosis (RRTB) may remain a source of infection longer than patients with rifampicin sensitive-tuberculosis (RS-TB). This study aimed to detect active cases of RS-TB and RR-TB through systematic screening among household contacts of RR-TB patients in Dhaka, Bangladesh. Methods: This cross-sectional study was conducted among the 355 household contacts (HHCs) of 93 RR-TB primary cases identified from various centres in Dhaka, diagnosed between November 2020 and October 2021. For the identification of active cases of tuberculosis (TB), systematic screening among HHCs was done, where verbal screening was performed to check the presence of symptoms of TB. Those who had at least one symptoms of TB were considered as symptomatic contacts. Later GeneXpert analysis of sputum was done among the screened symptomatic contacts. Data was collected using a pretested, semi-structured, interviewer-administered questionnaire. Results: An estimated 30.4 % of respondents were ≤ 15 years of age. TBlike symptoms were prevalent among 9.9 % of respondents. Loss of appetite (45.7 %), unexplained weight loss (40.0 %) and cough (37.1 %) were the most common symptoms. Among the contacts with TB-like symptoms, 6.7 % were diagnosed as a case of TB (3.35 % were RR-TB and 3.35 % were RS-TB). The number needed to be screened to find an active case of TB was established at 178 among the HHCs of RR-TB. Conclusions: About one in ten RR-TB HHCs showed TB-like symptoms. One in fifteen HHCs with TB-like symptoms was an active case of TB. Regular, effective screening of RR-TB contacts is needed to stop the transmission.